imatinib
Showing 1 - 25 of 124
Inherited Bone Marrow Failure Syndrome, Familial Platelet Disorder With Predisposition to Myeloid Malignancies Trial run by the
Not yet recruiting
- Inherited Bone Marrow Failure Syndrome
- Familial Platelet Disorder With Predisposition to Myeloid Malignancies
- imatinib
- TruSight Oncology
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 20, 2023
Melanoma Stage III, Melanoma Stage IV Trial in San Francisco (Binimetinib, Imatinib)
Recruiting
- Melanoma Stage III
- Melanoma Stage IV
- Binimetinib
- Imatinib
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 6, 2022
GIST Trial in Xi'an (Imatinib)
Recruiting
- GIST
- Imatinib
-
Xi'an, Shaanxi, ChinaXijing Hospital of Air Force Military Medical University
Jun 8, 2023
Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck Trial in Madison (Cetuximab, Imatinib)
Recruiting
- Head and Neck Cancer
- Squamous Cell Carcinoma of Head and Neck
- Cetuximab
- Imatinib
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Apr 24, 2023
Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission Trial (Asciminib, Imatinib)
Not yet recruiting
- Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission
- Asciminib
- Imatinib
- (no location specified)
Jun 7, 2022
Gastrointestinal Stromal Tumors Trial in Lexington (Imatinib)
Not yet recruiting
- Gastrointestinal Stromal Tumors
- Imatinib
-
Lexington, KentuckyMarkey Cancer Center
Aug 5, 2022
Sarcoma Trial in Helsinki (Imatinib)
Recruiting
- Sarcoma
- Imatinib
-
Helsinki, FinlandHelsinki University Central Hospital
Sep 26, 2022
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Trial in Frankfurt (Imatinib, Ponatinib, Blinatumomab)
Recruiting
- Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
- Imatinib
- +3 more
-
Frankfurt, GermanyDepartment of Medicine, Hematology and Oncology, Goethe Universi
Sep 24, 2023
Gastrointestinal Stromal Tumors Trial in Tokyo (Pimitespib, Imatinib, Sunitinib)
Recruiting
- Gastrointestinal Stromal Tumors
- Pimitespib
- +2 more
-
Tokyo, JapanA site selected by Taiho Pharmaceutical Co., Ltd.
Aug 4, 2022
Advanced, Refractory Cancer Trial in Seoul (Imatinib)
Active, not recruiting
- Advanced, Refractory Cancer
- Imatinib
-
Seoul, Korea, Republic ofSamsung Medical Center
Jun 13, 2022
Tuberculosis Trial in Atlanta (Imatinib, Isoniazid, Rifabutin)
Recruiting
- Tuberculosis
- Imatinib
- +2 more
-
Atlanta, GeorgiaEmory University DAIDS TB Non-Network CRS
Jan 20, 2022
CML, Chronic Phase Trial in Harbin (Flumatinib, Imatinib)
Not yet recruiting
- CML, Chronic Phase
- Flumatinib
- Imatinib
-
Harbin, Heilongjiang, ChinaInstitute of Hematology and Oncology, Harbin The First Hospital
May 5, 2022
ALK+ Anaplastic Large Cell Lymphoma Trial in Wien (Brentuximab vedotin, Imatinib)
Terminated
- ALK+ Anaplastic Large Cell Lymphoma
- Brentuximab vedotin
- Imatinib
-
Wien, AustriaUniversitätsklinik f. Innere Medizin I, AKH Wien, Klinische Abte
Feb 15, 2022
Chronic Phase Chronic Myelogenous Leukemia Trial in Detroit, Milwaukee (Asciminib, Imatinib)
Recruiting
- Chronic Phase Chronic Myelogenous Leukemia
- Asciminib
- Imatinib
-
Detroit, Michigan
- +1 more
May 3, 2022
Eosinophilic Myeloid Tumor, Hypereosinophilic Syndrome Trial run by the National Institute of Allergy and Infectious Diseases
Recruiting
- Eosinophilic Myeloid Neoplasm
- Hypereosinophilic Syndrome
- Imatinib
- Ruxolitinib
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
CML, Chronic Myelogenous Leukemia, Leukemia, Myeloid Chronic Trial in Worldwide (Asciminib add-on, Imatinib, Nilotinib)
Recruiting
- CML
- +3 more
- Asciminib add-on
- +3 more
-
Augusta, Georgia
- +46 more
Jan 23, 2023
Chronic Myeloid Leukemia, Chronic Phase Trial in Beijing (Radotinib, Imatinib)
Active, not recruiting
- Chronic Myeloid Leukemia, Chronic Phase
- Radotinib
- Imatinib
-
Beijing, ChinaPeking University People's Hospital(北京大学人民医院)
Jan 3, 2022
Acute Leukemia Trial in Tianjin (Flumatinib, Imatinib)
Recruiting
- Acute Leukemia
- Flumatinib
- Imatinib
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Sep 27, 2021
Covid19, Coronavirus Disease 2019, SARS-CoV-2 Acute Respiratory Disease Trial in Helsinki (Imatinib, Infliximab)
Recruiting
- Covid19
- +2 more
- Imatinib
- Infliximab
-
Helsinki, FinlandUniversity of Helsinki
Apr 27, 2022
Rare Malignant Tumor Trial (Imatinib)
Not yet recruiting
- Rare Malignant Neoplasm
- Imatinib
- (no location specified)
Nov 1, 2023
Progression-free Survival, Gastrointestinal Stromal Tumor, Neoadjuvant Trial in Hangzhou (Imatinib)
Recruiting
- Progression-free Survival
- +2 more
- Imatinib
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, College of Medicine, Zhejiang Uni
Oct 9, 2021
Gastrointestinal Stromal Tumors Trial in Seoul (imatinib)
Active, not recruiting
- Gastrointestinal Stromal Tumors
- imatinib
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Jun 22, 2021
Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated
Completed
- Chronic Myeloid Leukaemia
- Imatinib
-
Rionero in Vulture, Potenza, Italy
- +32 more
Oct 24, 2022